| 000 | 00934nam a2200277#a 4500 | ||
|---|---|---|---|
| 001 | 0000026500 | ||
| 002 | 3686 | ||
| 003 | NIH | ||
| 005 | 20240220145608.0 | ||
| 008 | 240220s2003 xx 000 0 eng d | ||
| 020 | _a9241545364 | ||
| 040 | _aIKU | ||
| 041 | _aeng | ||
| 060 | _aQV 738 MW6 | ||
| 245 | 4 | _aThe International pharmacopoeia. Vol.5, Tests and general requirements for dosage forms; Quality specifications for pharmaceutical substances and tablets | |
| 250 | _a3rd ed. | ||
| 260 |
_aGeneva, Switzerland: _bWorld Health Organization, _c2003 |
||
| 300 |
_axviii, 371 p.: _bill.; _c23cm |
||
| 650 | 1 | 0 |
_aAntimalarials _xstandards |
| 650 | 2 | 0 |
_aPharmaceutical preparations _xanalysis |
| 650 | 2 | 0 |
_aPharmaceutical preparations _xstandards |
| 650 | 2 | 0 |
_aTablets _xstandards |
| 710 | _aTitle: Quality specifications for pharmaceutical substaces and dosage forms | ||
| 710 | _aWorld Health Organization | ||
| 942 | _cOS | ||
| 999 |
_c26705 _d26705 |
||